U.S. Appeals Court Rules For Hanmi In AZ Patent-Infringement Suit
This article was originally published in PharmAsia News
Executive Summary
A U.S. appeals court ruled that Hanmi Pharmaceuticals did not infringe on AstraZeneca's patent for its Nexium (esomprazole magnesium) heartburn drug.